完整性与破裂性胸主动脉瘤腔内修复术的远期结局
该单中心回顾性研究纳入1999至2014年接受TEVAR的77例胸主动脉瘤患者(完整49例、破裂28例),完整者5年生存62.5%,破裂者3年生存仅27.8%,破裂修复后长期死亡风险显著升高(年龄校正HR 4.4),需优化患者选择。
要点
- 完整TAA的TEVAR围术期死亡低,5年生存62.5%。
- 破裂TAA修复后3年生存仅27.8%,多数死亡与主动脉事件相关。
- 两组5年再干预率分别为13.2%和17.9%,均发生于14个月内。
核心结论
- 完整TAA的TEVAR围术期死亡率低,5年生存率可接受为62.5%。
- 破裂TAA修复后结局较差,3年随访时三分之二患者死亡。
- 需改进患者选择以识别真正能从破裂TAA修复中获益者。
研究设计与样本
- 共77例,其中完整TAA 49例,破裂TAA 28例。
主要发现
- 完整TAA修复后30天生存95.9%,90天91.8%,5年62.5%。
- 90天后发生6例主动脉相关死亡(完整3例、破裂3例),其中5例为未处理主动脉段破裂。
- 年龄校正长期死亡风险比:破裂TAA相比完整TAA为4.4。
临床怎么用
- 完整TAA的TEVAR可作为围术期风险低且5年生存可接受的治疗选择。
- 破裂TAA修复后长期生存差,应严格评估患者是否真正获益。
- TEVAR后14个月内需密切监测再干预及未处理主动脉段破裂风险。
局限性
- 单中心回顾性研究,样本量较小(77例)。
- 破裂TAA组随访超过5年者仅1例存活,远期数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess long-term outcome after thoracic endovascular aortic repair (TEVAR) for thoracic aortic aneurysm (TAA). METHODS: All patients who underwent TEVAR for TAA at Uppsala University Hospital from December 1999 to December 2014 were included. Characteristics of the patients and outcome data were collected from medical records, national population registry, and cause of death registry. Perioperative survival was analyzed with the χ2 test, and 5-year survival was estimated with Kaplan-Meier analysis. Predictors of long-term survival were assessed with Cox regression. RESULTS: There were 77 patients included in the study, 49 with intact TAAs (iTAAs) and 28 with ruptured TAAs (rTAAs). Mean follow-up was 83.7 months for iTAA patients and 82.0 months for rTAA patients (P = .853). Mean age was 71.5 years for iTAA patients and 74.8 years for rTAA patients (P = .04). Survival after iTAA repair was 95.9% at 30 days, 91.8% at 90 days, and 62.5% at 5 years. After rTAA repair, survival was 71.4% at 30 days and decreased to 57.1% at 90 days (P < .01), with most deaths after 30 days being related to the aortic event. The 3-year survival rate after rTAA repair was 27.8%, and only one rTAA patient with 5 years of follow-up remained alive. Six aorta-related deaths occurred after 90 days (three iTAA patients, three rTAA patients); five were due to rupture of nontreated aortic segments. The 5-year reintervention rate was 13.2% for iTAA patients and 17.9% for rTAA patients (P = .682). All reinterventions occurred within 14 months of TEVAR. The age-adjusted hazard ratio for long-term mortality was 4.4 after rTAA repair compared with iTAA repair. CONCLUSIONS: TEVAR for iTAA was associated with low perioperative mortality and acceptable 5-year survival at 62.5%. Results were more pessimistic after rTAA repair, however, for which two-thirds of the patients were deceased at 3-year follow-up. Improved selection of patients is necessary to identify patients who are likely to truly benefit from rTAA repair.
引用
- Hellgren T, Wanhainen A, Steuer J, et al. Outcome of endovascular repair for intact and ruptured thoracic aortic aneurysms. J Vasc Surg. 2017. PMID: 28216352. doi:10.1016/j.jvs.2016.12.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。